Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium; ; et al in American Journal of Physiology - Heart and Circulatory Physiology (2007), 292(2), 1095-1104 The in vivo cardiac differentiation and functional effects of unmodified adult bone marrow mesenchymal stem cells (MSCs) after myocardial infarction (MI) is controversial. We postulated that ex vivo ... [more ▼] The in vivo cardiac differentiation and functional effects of unmodified adult bone marrow mesenchymal stem cells (MSCs) after myocardial infarction (MI) is controversial. We postulated that ex vivo pretreatment of autologous MSCs using cardiomyogenic growth factors will lead to cardiomyogenic specification and will result in superior biological and functional effects on cardiac regeneration of chronically infarcted myocardium. We used a chronic dog MI model generated by ligation of the coronary artery (n = 30). Autologous dog bone marrow MSCs were isolated, culture expanded, and specified into a cardiac lineage by adding growth factors, including basic FGF, IGF-1, and bone morphogenetic protein-2. Dogs underwent cell injection > 8 wk after the infarction and were randomized into two groups. Group A dogs (n = 20) received MSCs specified with growth factors (147 +/- 96 x 10(6)), and group B (n = 10) received unmodified MSCs (168 +/- 24 x 10(6)). After the growth factor treatment, MSCs stained positive for the early muscle and cardiac markers desmin, antimyocyte enhancer factor-2, and Nkx2-5. In group A dogs, prespecified MSCs colocalized with troponin I and cardiac myosin. At 12 wk, group A dogs showed a significantly larger increase in regional wall thickening of the infarcted territory (from 22 +/- 8 to 32 +/- 6% in group A; P < 0.05 vs. baseline and group B, and from 19 +/- 7 to 21 +/- 7% in group B, respectively) and a decrease in the wall motion score index (from 1.60 +/- 0.05 to 1.35 +/- 0.03 in group A; P < 0.05 vs. baseline and group B, and from 1.58 +/- 0.07 vs. 1.56 +/- 0.08 in group B, respectively). The biological ex vivo cardiomyogenic specification of adult MSCs before their transplantation is feasible and appears to improve their in vivo cardiac differentiation as well as the functional recovery in a dog model of the chronically infarcted myocardium. [less ▲] Detailed reference viewed: 38 (1 ULg) Pretreatments and enzymatic hydrolysis of Miscanthus x giganteus for oligosaccharides production: delignification degree and characterisation of the hydrolysis productsVanderghem, Caroline ; Jacquet, Nicolas ; Blecker, Christophe et alPoster (2010, February 04) The aim of the present study is to compare two delignification methods (formic/acetic acid1 and soaking in aqueous ammonia) on Miscanthus x giganteus and to assess the suitability to produce cellobiose ... [more ▼] The aim of the present study is to compare two delignification methods (formic/acetic acid1 and soaking in aqueous ammonia) on Miscanthus x giganteus and to assess the suitability to produce cellobiose and other oligosaccharides after enzymatic hydrolysis. Oligosaccharides have recently gotten attention for their health benefits. Two methods were compared in order to quantify lignin: the acid detergent lignin method (procedure of Van Soest most commonly employed by animal scientist and agronomists for analysis of forages) and the Klason lignin procedure. Lignin concentrations in raw material determined by both methods were different; Klason lignin value (23.5%) was greater than the acid detergent lignin concentration (12.9%). Possible reasons of these results will be discussed. Pretreatment by the formic/acid mixture showed a better deliginification rate compared to the soaking in aqueous ammonia method. Results were based on Klason lignin. Analysis of the structural carbohydrates revealed that untreated miscanthus was mainly composed of glucose and xylose. Extracted pulps by both delignification methods were hydrolysed by commercial cellulases and hemicellulases. A major challenge is the characterisation of complex mixtures of lignocellulosic hydrolysates. In this study, the hydrolysis products were separated and quantified by highperformance anion exchange chromatography with pulsed amperometric detection (HPAECPAD). This method was successfully applied to the quantitative analysis of monosaccharides (glucose and xylose) and disaccharides (cellobiose and xylobiose) formed by the enzymatic hydrolysis of pretreated miscanthus. The influence of the pretreatments on the oligosaccharides yields will be presented. [less ▲] Detailed reference viewed: 25 (4 ULg) 'Pretty Happy!'Delville, Michel ![]() in Literary Review (2002), 46(1), 196-199 Detailed reference viewed: 9 (2 ULg) La preuve de la réception des travaux dans la loi Breyne. Note sous Mons, 19 janvier 2011Kohl, Benoît ![]() in Revue de Jurisprudence de Liège, Mons et Bruxelles (2012) Detailed reference viewed: 6 (0 ULg) La preuve du contrat conclu par voie électronique – clap 2èmeLecocq, Pascale ; Vanbrabant, Bernard ![]() in Actualités du Droit (2002), 3 Detailed reference viewed: 12 (0 ULg)![]() "La preuve du contrat conclu par voie électronique"Lecocq, Pascale ; Vanbrabant, Bernard ![]() in Le commerce électronique : un nouveau mode de contracter ? (2001) Preuve et aperçu de la loi PhenixLecocq, Pascale ![]() Conference given outside the academic context (2005) Preuve et conséquences de la séparation de fait en matière d’assujettissement et d’établissement de l’impôt des personnes physiquesOrban, Lionel ![]() in Commission Université-Palais – Formation permanente – Droit fiscal. Volume XIV – Février 1997 (1997) Detailed reference viewed: 94 (2 ULg) « Preuve et signature électronique des actes juridiques »,Lecocq, Pascale ![]() in Delnoy, Paul (Ed.) Chronique de droit à l'usage des juges de paix et de police 2003 (2003, January) La preuve scientifique évitée. Inventaire de quelques techniques judiciairesSibony, Anne-Lise ![]() in Preuve scientifique, preuve juridique (2012) Detailed reference viewed: 32 (1 ULg) La preuve scientifique évitée: Inventaire de quelques techniques judiciairesSibony, Anne-Lise ![]() in Thruilhé-Marengo, Eve (Ed.) Preuve scientifique, preuve juridique (2011) Cet article envisage différentes techniques par lesquelles une juridiction peut éviter d'avoir à examiner des preuves scientifiques là même où elles pourraient être pertinentes. Detailed reference viewed: 31 (1 ULg) La preuveLecocq, Pascale ; Guerra, Vincent ![]() Scientific conference (2005) Detailed reference viewed: 2 (0 ULg) The prevalence and burden of arthritisReginster, Jean-Yves ![]() in Rheumatology (2002), 41(Suppl. 1), 3-7 The prevalence of arthritis is high, with osteoarthritis (OA) being one of the most frequent disorders in the population. In England and Wales, between 1.3 and 1.75 million people have OA and a further 0 ... [more ▼] The prevalence of arthritis is high, with osteoarthritis (OA) being one of the most frequent disorders in the population. In England and Wales, between 1.3 and 1.75 million people have OA and a further 0.25 0.5 million have rheumatoid arthritis (RA), while in France some 6 million new diagnoses of OA Lire made each year. In 1997, similar to16%, of the US population had some form of arthritis. This prevalence is expected to increase in the coining years, as arthritis more often affects the elderly, a proportion of the population that is increasing. The economic burden of such musculoskeletal diseases is also high, accounting for up to 1-2.5%, of the gross national product of western nations. This burden comprises both the direct costs of medical interventions and indirect costs, such as premature mortality and chronic and short-term disability. The impact of arthritis on quality of life is of particular importance. Musculoskeletal disorders are associated with some of the poorest quality-of-life issues, particularly in terms of bodily pain (mean score from the MOS 36-item Short Form Health Survey of 52.1) and physical functioning (49.9), where quality of life is lower than that for gastrointestinal conditions (bodily pain 52.9, physical functioning 55.4), chronic respiratory diseases (72.7, 65.4) and cardiovascular conditions (64.7, 59.3). [less ▲] Detailed reference viewed: 14 (1 ULg) Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia; ; et al in European Journal of Gastroenterology & Hepatology (2009), 21(9), 1001-1007 Objective Epstein–Barr virus (EBV) has been linked to gastric carcinoma (GC) with worldwide geographical variations of prevalence ranging from 1 to 18% of cases. Investigations carried out in north Africa ... [more ▼] Objective Epstein–Barr virus (EBV) has been linked to gastric carcinoma (GC) with worldwide geographical variations of prevalence ranging from 1 to 18% of cases. Investigations carried out in north Africa have shown that some EBV-associated types of cancers are common in this area. This study was taken to determine the prevalence of EBV-associated GC in Tunisia. Methods Ninety-six nonselected GC cases (male/female ratio 1.7/1, mean age 60.9 years, range: 20–88 years) were evaluated for the presence of EBV by polymerase chain reaction as well as by in-situ hybridization for EBVencoded small RNAs (EBERs) and immunohistochemistry for LMP-1 and EBNA-2 expression. Results EBV was detected by polymerase chain reaction in 36% of cases, whereas EBERs were detected in the tumor cells in only four cases (4.1%). Immunohistochemistry for LMP-1 and EBNA-2 was negative in all cases. The mean age for patients harboring EBERs-positive GC was 55.7 years (range: 52–59 years). All EBERs-positive GC cases were males of advanced clinical stage (pT3–pT4). According to Lauren’s classification, two cases were of diffuse histological type and two cases were of intestinal type. In three cases, the tumors have a proximal location and in the remaining case the tumor arises in the antrum. All EBV strains detected from EBV-associated GC were exclusively of type A and D, prototype F, and XhoI-maintained variant. Conclusion We conclude that the prevalence of EBV-associated GC in Tunisia is low (4.1%), suggesting that this virus is not an important etiological factor in GC arising in north African populations. The clinicopathological profile of EBV-associated GC in Tunisia did not differ markedly from that found elsewhere. [less ▲] Detailed reference viewed: 6 (0 ULg) Prevalence and characteristics of the MMTV-like associated breast carcinomas in TunisiaHachana, Mohamed Ridha ; ; et alin Cancer Letters (2008), 271(2), 222-230 The involvement of a retrovirus homologous to the mouse mammary tumor virus (MMTV) in the pathogenesis of human breast cancer (BC) has long been assumed, but has never been proven. Previous studies have ... [more ▼] The involvement of a retrovirus homologous to the mouse mammary tumor virus (MMTV) in the pathogenesis of human breast cancer (BC) has long been assumed, but has never been proven. Previous studies have reported the detection of MMTV-like env sequences in variable proportions that did not exceed 40% of BC cases in several countries. However, these viral sequences have been found in higher proportion (74%) in Tunisian diagnosed with BC during the seventies. This study is an attempt to evaluate the current prevalence of MMTV-like env gene in BC in Tunisian women. We used semi-nested PCR that amplify a 190-bp MMTV-like env sequence, followed by direct sequencing to screen a series of 122 cases of BC randomly selected. The findings were correlated to clinicopathological data and immunohistochemical expression status of progesterone and oestrogen receptors, HER2, and P53. Specific MMTV-like env sequences were found in 17 (13.9%) cases of breast carcinomas, whereas the same sequences were not detected in matched normal breast tissues. The presence of the viral sequences correlates inversely with progesterone receptor expression (6.8% versus 20.3%; P = 0.03) and HER2 overexpression (3.1% versus 17.7%; P = 0.04). This present study confirms the presence of MMTV-like env sequences in BC in Tunisian women but describes an important decrease in the prevalence of the viral sequences compared with pervious studies. This reduction may be due to some changes in the virological characteristics or exposure to the virus. [less ▲] Detailed reference viewed: 3 (0 ULg)![]() Prevalence and characterization of Microsporum canis asymptomatic carriage in catsMignon, Bernard ; Losson, Bertrand ![]() Poster (1995) Detailed reference viewed: 14 (1 ULg) Prevalence and characterization of Microsporum canis carriage in cats.Mignon, Bernard ; Losson, Bertrand ![]() in Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology (1997), 35(4), 249-256 In order to determine the prevalence and to characterize the carriage of Microsporum canis in cats, different mycological examinations (including a culture obtained by hair brushing and Wood's light ... [more ▼] In order to determine the prevalence and to characterize the carriage of Microsporum canis in cats, different mycological examinations (including a culture obtained by hair brushing and Wood's light examination) were performed on 632 animals of different origins. Group 1 comprised 467 healthy pet cats belonging to veterinary students. In this group, prevalence of carriage was 2.1%: eight cats were asymptomatic transient carriers and one cat was an asymptomatic infected animal presenting discrete Wood's-positive lesions disseminated on the whole body that were visible after sedation and clipping. The carriage prevalence was higher (15.7%) in group 2 comprising 134 European cats destroyed in a pound and kept together. In two additional groups of cats, it was shown that an infected cat was responsible for the dissemination of fungal material into its environment including the other in-contact animals. When the active source of fungus was removed, the dissemination stopped, resulting in a decrease in the amount of infective material recovered from both the animal carriers and the environmental surfaces. This was also observed in two experimental groups of guinea pigs. No association between feline immunodeficiency virus infection and the M. canis carriage was observed in a retrospective case-control study performed on group 2. None of these cats was feline leukaemia virus positive. [less ▲] Detailed reference viewed: 22 (2 ULg) Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001; ; et al in European Journal of Endocrinology (2004), 151(1), 67-72 Objective: Since the availability of recombinant human growth hormone (rhGH) all children with growth hormone deficiency (GHD) living in Belgium are offered rhGH treatment after approval by a peer-review ... [more ▼] Objective: Since the availability of recombinant human growth hormone (rhGH) all children with growth hormone deficiency (GHD) living in Belgium are offered rhGH treatment after approval by a peer-review board. In this study, we evaluated the prevalence and demographic features of childhood GHD in Belgium during the period 1986-2001 and we compared them with the data from other countries. Methods: Diagnostic, demographic and baseline auxological data of 714 children diagnosed as having GHD between 1986 and 2001 were retrieved from the database of the Belgian Study Group for Paediatric Endocrinology. Results: The prevalence of GHD in Belgium was estimated to be 1/5600. The origin of GHD was idiopathic (idGHD) in 41% of the patients, congenital (congGHD) in 20% and acquired (acqGHD) in 35%. During the first 4 years (1986-1989) more patients were classified as idGHD; thereafter the distribution between the three aetiology groups did not change. In all groups, boys outnumbered girls but this preponderance was especially pronounced in congGHD patients (male:female = 4:1) with a central malformation that associates an anterior pituitary hypoplasia, a missing, fine or normal pituitary stalk and an ectopic posterior pituitary. Thirteen percent of the patients with idGHD, 50% with congGHD and 52% with acqGHD had multiple pituitary deficiencies. Patients with congGHD were the youngest (mean+/-S.D. age: 6.5+/-4.7 years) and were the shortest (-3.0+/-1.3 standard deviation score (SDS)) at the start of rhGH treatment. There was no time trend over the studied period for age and height at onset of GH therapy. Conclusion: In Belgium, the prevalence of childhood GHD can be estimated as 1/5600 which is comparable to other recent surveys. The yearly number of new patients for the different aetiologies and the auxological parameters have remained relatively constant over the last 16 years. [less ▲] Detailed reference viewed: 14 (0 ULg) Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.; ; et al in AIDS Research and Human Retroviruses (2008), 24(3), 355-62 This study is the first prospective study to assess the prevalence, epidemiology, and risk factors of HIV-1 drug resistance in newly diagnosed HIV-infected patients in Belgium. In January 2003 it was ... [more ▼] This study is the first prospective study to assess the prevalence, epidemiology, and risk factors of HIV-1 drug resistance in newly diagnosed HIV-infected patients in Belgium. In January 2003 it was initiated as part of the pan-European SPREAD program, and continued thereafter for four inclusion rounds until December 2006. Epidemiological, clinical, and behavioral data were collected using a standardized questionnaire and genotypic resistance testing was done on a sample taken within 6 months of diagnosis. Two hundred and eighty-five patients were included. The overall prevalence of transmitted HIV-1 drug resistance in Belgium was 9.5% (27/285, 95% CI: 6.6-13.4). Being infected in Belgium, which largely coincided with harboring a subtype B virus, was found to be significantly associated with transmission of drug resistance. The relatively high rate of baseline resistance might jeopardize the success of first line treatment as more than 1 out of 10 (30/285, 10.5%) viruses did not score as fully susceptible to one of the recommended first-line regimens, i.e., zidovudine, lamivudine, and efavirenz. Our results support the implementation of genotypic resistance testing as a standard of care in all treatment-naive patients in Belgium. [less ▲] Detailed reference viewed: 24 (4 ULg) |
||